• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday

    8/9/23 2:03:16 PM ET
    $AKAM
    $ARCT
    $ARRY
    $AVXL
    Real Estate
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKAM alert in real time by email

    U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

    • Tango Therapeutics, Inc. (NASDAQ:TNGX) gained 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.
    • Decibel Therapeutics, Inc. (NASDAQ:DBTX) rose 76% to $4.9150 after Regeneron announced it will acquire the company.
    • Mirati Therapeutics, Inc. (NASDAQ:MRTX) climbed 30.1% to $36.17 after the company reported second-quarter financial results. Also, B. Riley Securities upgraded the stock from Neutral to Buy and announced a $45 price target.
    • Array Technologies, Inc. (NASDAQ:ARRY) gained 27.8% to $22.85 following a second-quarter earnings beat.
    • Computer Task Group, Incorporated (NASDAQ:CTG) rose 27.8% to $10.23 after the company announced it will be acquired by Cegeka for $10.50 per share.
    • LivePerson, Inc. (NASDAQ:LPSN) gained 27.5% to $5.09 r after the company announced a second-quarter earnings beat. The company named John Collins as the Interim CEO.
    • PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) climbed 22.3% to $8.31 after the company reported better-than-expected second-quarter EPS results.
    • Celsius Holdings, Inc. (NASDAQ:CELH) rose 21.8% to $174.73 after the company reported better-than-expected second-quarter financial results.
    • DMC Global Inc. (NASDAQ:BOOM) gained 19.8% to $21.03 following quarterly results.
    • Dutch Bros Inc. (NYSE:BROS) climbed 19.8% to $33.55 after the company reported better-than-expected quarterly EPS results and issued FY23 guidance.
    • Azenta, Inc. (NASDAQ:AZTA) rose 19.6% to $57.45 fter the company reported better-than-expected third-quarter financial results and issued fourth-quarter EPS guidance above estimates. Additionally, Needham raised its price target from $55 to $65 on the stock.
    • ThredUp Inc. (NASDAQ:TDUP) gained 19.5% to $3.85 after the company reported better-than-expected second-quarter financial results and issued revenue guidance. Also, Goldman Sachs raised its price target from $3 to $4 on the stock.
    • Taboola.com Ltd. (NASDAQ:TBLA) gained 17% to $3.9450 after the company reported better-than-expected second-quarter financial results and raised its FY23 revenue guidance.
    • Anavex Life Sciences Corp. (NASDAQ:AVXL) jumped 16.2% to $ 9.33.
    • Rapid7, Inc. (NASDAQ:RPD) rose 16% to $46.15 after the company reported better-than-expected second-quarter financial results and issued FY23 EPS guidance above estimates. Additionally, Morgan Stanley raised its price target from $48 to $52 on the stock.
    • Toast, Inc. (NASDAQ:TOST) jumped 15.7% to $23.39 after the company reported mixed quarterly financial results and issued FY23 revenue guidance above estimates.
    • Marqeta, Inc. (NASDAQ:MQ) rose 15.5% to $5.73 following strong quarterly sales.
    • IDEAYA Biosciences, Inc. (NASDAQ:IDYA) jumped 15.5% to $24.93 after SVB Leerink initiated coverage on the stock with an Outperform rating and announced a $33 price target.
    • SciPlay Corporation (NASDAQ:SCPL) gained 15.4% to $22.67 after the company reported better-than-expected second-quarter financial results.
    • Orthofix Medical Inc. (NASDAQ:OFIX) jumped 15.3% to $20.72 after the company reported better-than-expected second-quarter financial results and raised FY23 net sales guidance above estimates.
    • Axon Enterprise, Inc. (NASDAQ:AXON) surged 14.5% to $201.29 after the company reported better-than-expected second-quarter financial results and raised its FY23 revenue guidance above estimates.
    • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) rose 13.3% to $29.15.
    • Liberty Latin America Ltd. (NASDAQ:LILA) gained 13% to $9.49 after the company reported second-quarter revenue results..
    • Blink Charging Co. (NASDAQ:BLNK) jumped 12.9% to $6.98 after the company reported better-than-expected second-quarter financial results.
    • Oscar Health, Inc. (NYSE:OSCR) rose 12.7% to $8.04 following quarterly results.
    • HNI Corporation (NYSE:HNI) gained 10.8% to $32.24 following strong quarterly earnings.
    • Vertex, Inc. (NASDAQ:VERX) rose 9.9% to $19.53 after the company reported better-than-expected second-quarter revenue results and issued third-quarter revenue guidance above estimates.
    • PENN Entertainment, Inc. (NASDAQ:PENN) rose 9.8% to $27.27 after the company reported better-than-expected second-quarter financial results and announced an exclusive U.S. online sports betting agreement with ESPN.
    • Zai Lab Limited (NASDAQ:ZLAB) gained 9.7% to $26.52.
    • Duolingo, Inc. (NASDAQ:DUOL) gained 9.3% to $148.66 after the company reported better-than-expected second-quarter financial results.
    • Coupang, Inc. (NYSE:CPNG) rose 8.5% to $19.44 after the company reported better-than-expected second-quarter financial results.
    • Akamai Technologies, Inc. (NASDAQ:AKAM) gained 8.4% to $102.91 after the company reported better-than-expected second-quarter financial results and issued FY23 adjusted EPS and revenue guidance above estimates.
    • The Goodyear Tire & Rubber Company (NASDAQ:GT) rose 5% to $13.49.

    Read More: Genpact Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

    Get the next $AKAM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKAM
    $ARCT
    $ARRY
    $AVXL

    CompanyDatePrice TargetRatingAnalyst
    Marqeta Inc.
    $MQ
    2/17/2026$6.00Overweight
    Analyst
    Vertex Inc.
    $VERX
    2/12/2026$16.00Buy → Hold
    Jefferies
    Oscar Health Inc.
    $OSCR
    2/12/2026$18.00Mkt Perform → Outperform
    Raymond James
    Rapid7 Inc.
    $RPD
    2/11/2026$9.00Buy → Neutral
    UBS
    Rapid7 Inc.
    $RPD
    2/11/2026$10.00Buy → Hold
    Canaccord Genuity
    Coupang Inc.
    $CPNG
    2/5/2026$17.00Underperform
    Bernstein
    Vertex Inc.
    $VERX
    2/3/2026$20.00Overweight → Neutral
    Piper Sandler
    Toast Inc.
    $TOST
    2/2/2026$42.00 → $36.00Neutral
    DA Davidson
    More analyst ratings

    $AKAM
    $ARCT
    $ARRY
    $AVXL
    SEC Filings

    View All

    SEC Form 10-K filed by Akamai Technologies Inc.

    10-K - AKAMAI TECHNOLOGIES INC (0001086222) (Filer)

    2/20/26 4:14:22 PM ET
    $AKAM
    Real Estate

    SEC Form 10-K filed by Rapid7 Inc.

    10-K - Rapid7, Inc. (0001560327) (Filer)

    2/19/26 4:35:41 PM ET
    $RPD
    Computer Software: Prepackaged Software
    Technology

    Akamai Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AKAMAI TECHNOLOGIES INC (0001086222) (Filer)

    2/19/26 4:15:50 PM ET
    $AKAM
    Real Estate

    $AKAM
    $ARCT
    $ARRY
    $AVXL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Westphal Jeffrey bought $5,121,294 worth of shares (397,740 units at $12.88) (SEC Form 4)

    4 - Vertex, Inc. (0001806837) (Issuer)

    2/18/26 5:22:20 PM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Bercovich Michael bought $50,392 worth of shares (65,333 units at $0.77), increasing direct ownership by 53% to 188,563 units (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    12/12/25 6:08:54 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    President and CEO Battaglia Michael C. bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 14% to 267,095 units (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    12/12/25 6:07:33 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    $AKAM
    $ARCT
    $ARRY
    $AVXL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KRAZATI issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/14/22 7:40:10 AM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KRAZATI (ADAGRASIB) issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ADAGRASIB) (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/12/22 6:09:02 PM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KRAZATI (ADAGRASIB) issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ADAGRASIB) (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Efficacy

    12/12/22 4:56:01 PM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKAM
    $ARCT
    $ARRY
    $AVXL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on Marqeta with a new price target

    Analyst resumed coverage of Marqeta with a rating of Overweight and set a new price target of $6.00

    2/17/26 7:51:08 AM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    Vertex downgraded by Jefferies with a new price target

    Jefferies downgraded Vertex from Buy to Hold and set a new price target of $16.00

    2/12/26 7:24:07 AM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Oscar Health upgraded by Raymond James with a new price target

    Raymond James upgraded Oscar Health from Mkt Perform to Outperform and set a new price target of $18.00

    2/12/26 7:19:33 AM ET
    $OSCR
    Medical Specialities
    Health Care

    $AKAM
    $ARCT
    $ARRY
    $AVXL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gaming and Leisure Properties, Inc. Reports Record Fourth Quarter Results, Establishes 2026 Guidance and Declares 2026 First Quarter Dividend of $0.78 per Share

    WYOMISSING, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) ("GLPI" or the "Company") today announced record results for the fourth quarter and year-ended December 31, 2025. GLPI has posted a supplemental earnings presentation, which highlights the events of the quarter, recent developments, and future considerations, that can be accessed at www.glpropinc.com. Financial Highlights   Three Months Ended December 31, Year Ended December 31,(in millions, except per share data)  2025   2024   2025   2024 Total Revenue $407.0  $389.6  $1,594.8  $1,531.5 Income From Operations $363.4  $308.2  $1,201.5  $1,130.7 Net income $275.4  $223.6  $850.4  $807.6 FF

    2/19/26 4:15:00 PM ET
    $BALY
    $BYD
    $CZR
    Hotels/Resorts
    Consumer Discretionary
    Real Estate Investment Trusts
    Real Estate

    Akamai Reports Fourth Quarter 2025 and Full-Year 2025 Financial Results

    Fourth quarter highlights Revenue of $1.095 billion, up 7% year-over-year and up 6% when adjusted for foreign exchange*Cloud Infrastructure Services** revenue of $94 million, up 45% year-over-year and up 44% when adjusted for foreign exchange*Security revenue of $592 million, up 11% year-over-year and up 9% when adjusted for foreign exchange*; Guardicore Segmentation and API Security revenue of $90 million, up 36% year-over-year and up 34% when adjusted for foreign exchange*GAAP net income per diluted share of $0.58, down 36% year-over-year and when adjusted for foreign exchange*, and non-GAAP net income per diluted shared* of $1.84, up 11% year-over-year and when adjusted for foreign excha

    2/19/26 4:01:00 PM ET
    $AKAM
    Real Estate

    ModelFront Announces General Availability of Automatic Post-Editing

    Additional LLM to grow automation now included by default for all customers. ModelFront today announced the general availability of automatic post-editing (APE), an additional private custom large language model. First rolled out in 2024, APE is now rolled out to all ModelFront customers in production and included by default from day one. ModelFront's quality prediction (QP) is AI to check and fix AI translations. It automatically verifies segments that humans would verify unedited, and triggers human intervention for those that need it. Enterprise translation buyers use QP to automate and scale while keeping human quality. While QP alone successfully automated segments that profess

    2/19/26 8:57:00 AM ET
    $CG
    $CPNG
    $GOOGL
    Investment Managers
    Finance
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AKAM
    $ARCT
    $ARRY
    $AVXL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Mcgowan Edward J converted options into 13,923 shares and covered exercise/tax liability with 4,830 shares, increasing direct ownership by 55% to 25,535 units (SEC Form 4)

    4 - AKAMAI TECHNOLOGIES INC (0001086222) (Issuer)

    2/20/26 5:52:51 PM ET
    $AKAM
    Real Estate

    EVP - Global Sales Joseph Paul C converted options into 10,313 shares and covered exercise/tax liability with 3,288 shares, increasing direct ownership by 40% to 24,538 units (SEC Form 4)

    4 - AKAMAI TECHNOLOGIES INC (0001086222) (Issuer)

    2/20/26 5:50:44 PM ET
    $AKAM
    Real Estate

    COO & GM Edge Technology Group Karon Adam converted options into 16,846 shares and covered exercise/tax liability with 6,444 shares, increasing direct ownership by 134% to 18,187 units (SEC Form 4)

    4 - AKAMAI TECHNOLOGIES INC (0001086222) (Issuer)

    2/20/26 5:49:01 PM ET
    $AKAM
    Real Estate

    $AKAM
    $ARCT
    $ARRY
    $AVXL
    Leadership Updates

    Live Leadership Updates

    View All

    Evolv Technology Announces the Appointment of Henrik Kühl as a New Independent Director

    – Long-Time Member of the Board of Directors and Early Venture Capitalist Bilal Zuberi Resigns from Board – Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced the appointment of Mr. Henrik Kühl, age 46, to its Board of Directors ("Board") effective February 12, 2026. Kühl will also serve on the Board's Audit Committee. The Board affirmatively determined that Kühl is independent and an audit committee financial expert as that term is defined by applicable Securities and Exchange Commission regulations. Kühl is an accomplished leader with over 25 years of experience in c

    2/12/26 8:00:00 AM ET
    $AXON
    $EVLV
    Ordnance And Accessories
    Industrials
    Computer peripheral equipment
    Technology

    Celsius Holdings Appoints Christy Jacoby and John Short to the Company's Board of Directors

    Celsius Holdings, Inc. (NASDAQ:CELH) ("Celsius Holdings" or "the Company") today announced the appointment of Christy Jacoby and John Short to its Board of Directors. Jacoby and Short were nominated by PepsiCo, Inc. ("PepsiCo") following the resignation of Israel Kontorovsky and Michael Del Pozzo from the Celsius Holdings Board, effective immediately. "We thank Israel and Mike for their service and contributions during an important period of growth and evolution for Celsius Holdings," said John Fieldly, Chairman and Chief Executive Officer of Celsius Holdings. "As we continue to scale with discipline, operating rigor and portfolio clarity, we believe Christy and John bring highly relevant

    2/10/26 4:30:00 PM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    Fox Factory Announces Strategic Board Refresh

    Company to Appoint Two New Independent Directors and Form Transformation Committee Focused on Operational Excellence and Margin Improvement Company Enters into Cooperation Agreement with Engine Capital DULUTH, Ga., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (Nasdaq: FOXF) ("Fox Factory" or the "Company"), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers worldwide, today announced that following constructive discussions with Engine Capital ("Engine Capital") regarding opportunities to enhance operational performance and profitability, the Company will be undertaking a strategic boar

    2/9/26 4:05:00 PM ET
    $FOXF
    $OFIX
    Motor Vehicles
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    $AKAM
    $ARCT
    $ARRY
    $AVXL
    Financials

    Live finance-specific insights

    View All

    Gaming and Leisure Properties, Inc. Reports Record Fourth Quarter Results, Establishes 2026 Guidance and Declares 2026 First Quarter Dividend of $0.78 per Share

    WYOMISSING, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) ("GLPI" or the "Company") today announced record results for the fourth quarter and year-ended December 31, 2025. GLPI has posted a supplemental earnings presentation, which highlights the events of the quarter, recent developments, and future considerations, that can be accessed at www.glpropinc.com. Financial Highlights   Three Months Ended December 31, Year Ended December 31,(in millions, except per share data)  2025   2024   2025   2024 Total Revenue $407.0  $389.6  $1,594.8  $1,531.5 Income From Operations $363.4  $308.2  $1,201.5  $1,130.7 Net income $275.4  $223.6  $850.4  $807.6 FF

    2/19/26 4:15:00 PM ET
    $BALY
    $BYD
    $CZR
    Hotels/Resorts
    Consumer Discretionary
    Real Estate Investment Trusts
    Real Estate

    Akamai Reports Fourth Quarter 2025 and Full-Year 2025 Financial Results

    Fourth quarter highlights Revenue of $1.095 billion, up 7% year-over-year and up 6% when adjusted for foreign exchange*Cloud Infrastructure Services** revenue of $94 million, up 45% year-over-year and up 44% when adjusted for foreign exchange*Security revenue of $592 million, up 11% year-over-year and up 9% when adjusted for foreign exchange*; Guardicore Segmentation and API Security revenue of $90 million, up 36% year-over-year and up 34% when adjusted for foreign exchange*GAAP net income per diluted share of $0.58, down 36% year-over-year and when adjusted for foreign exchange*, and non-GAAP net income per diluted shared* of $1.84, up 11% year-over-year and when adjusted for foreign excha

    2/19/26 4:01:00 PM ET
    $AKAM
    Real Estate

    Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences

    BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ:TNGX), today announced that it will report fourth quarter 2025 financial results on March 5, 2026, before the open of the U.S. financial markets. The company does not intend to hold a conference call. Additionally, Tango Therapeutics management is scheduled to participate in three upcoming investor conferences: TD Cowen 46th Annual Health Care Conference, Boston Corporate presentation on Wednesday, March 4 at 1:10-1:40 PM ETWebcast link here Barclays 28th Annual Global Healthcare Conference, Miami Hosting 1x1 meetings on Tuesday, March 10 2026 Leerink Partners Global Healthcare Conference, Miami Fireside chat

    2/18/26 7:00:00 AM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKAM
    $ARCT
    $ARRY
    $AVXL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PMV Pharmaceuticals Inc.

    SC 13G - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

    12/12/24 12:29:41 PM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Marqeta Inc.

    SC 13G/A - Marqeta, Inc. (0001522540) (Subject)

    11/27/24 8:47:26 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Tango Therapeutics Inc.

    SC 13G - Tango Therapeutics, Inc. (0001819133) (Subject)

    11/20/24 4:24:26 PM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care